Blood Pressure Drug Recalled Nationwide Over Metal Fragments
By @sharedot · · 6 pages
- Health
- Drug Recall
Breckenridge Pharmaceutical recalled one lot of 60mg propranolol extended-release capsules nationwide over possible metal contamination.
What was recalled and how to spot it
Breckenridge Pharmaceutical, Inc. issued a voluntary recall Monday for one lot of 60mg Propranolol Hydrochloride Extended-Release Capsules, a beta-blocker commonly used to treat high blood pressure and also prescribed for chest pain, migraines or tremors.
The affected medication comes in 100-count bottles with lot number PK25110035, an expiration date of May 2029, and National Drug Code 51991-817-01. According to Fox Business, the capsules were distributed nationwide to wholesalers and pharmacies between Oct. 26 and Nov. 4, 2026.
Consumers are advised to check their bottles immediately against these identifiers.
Why metal in capsules is a serious risk
The recall matters because use of product from the affected lot could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine, according to the company's press release.
The company said the affected lot shared intermediate material suspected to be the source of metal contamination identified in a separate lot that was never released to market. NBC 5 Chicago reports the 60 mg white capsules are manufactured by Adare Pharma.
Both outlets confirm the contamination could involve pieces of metal fragments inside the capsules themselves.
What consumers and pharmacies should do now
Breckenridge said it is not aware of any adverse events in connection with the recall, but urged anyone who experiences problems possibly related to the pills to contact a healthcare provider and report the incident through the FDA's MedWatch Adverse Event Reporting program.
Per Fox Business, the company advised consumers to immediately stop taking product from the affected lot, contact their physician for replacement instructions, and return any unused portion to the pharmacy where it was obtained.
Wholesalers, pharmacies and retailers are directed to check inventory, quarantine affected product, and stop distributing or dispensing it.
A pattern of blood pressure drug recalls
This is the latest in a series of recent blood pressure medication recalls.
NBC 5 Chicago reports an earlier November recall involved Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets, which were pulled because they did not dissolve properly, and that earlier this fall thousands of bottles of Chlorthalidone tablets were recalled for the same reason.
For patients managing hypertension, the string of recalls underscores the importance of checking lot numbers and expiration dates rather than assuming a prescription is safe, and of returning suspect pills to the dispensing pharmacy rather than discarding them at home.